Category: Federal Forum Posters
Purpose: Cancer patients near end-of-life will often receive aggressive treatments and non-essential medications. The focus should instead be on improving quality of life and simplification of regimen. Recent antineoplastic therapies have shifted and there are more options for cancer treatment. The objective of this study is to evaluate the quality of care services within the Veterans Affairs Medical Center.
Methods: This is a multi-centered, retrospective, chart review of deceased patients with metastatic melanoma, lung, prostate, colon, and pancreatic cancer between July 1,2016 to June 30th, 2018. The primary outcome will evaluate the incidence of antineoplastic therapy, immunotherapy, hormonal therapy, or cytotoxic chemotherapy, administration within 30 and 14 days of life and incidence of patients with at least one non-essential chronic medication dispensed within 30 and 14 days of life. Secondary outcomes include line of therapy, emergency room visits, time between diagnosis and death, hospice/palliative care referrals, non-essential medications, and discontinuation of non-essential medications. Data will be collected independently at Veterans Affairs Medical Centers. The data will be compiled and presented as one single study. At the Lexington Veterans Affairs Medical Center, approximately 150 subjects will undergo screening identified by the electronic medical record. The following data will be collected: age at death, sex, presence of palliative services, cancer diagnosis, antineoplastic therapy, total number of different antineoplastic regimens, any emergency visit related to cancer within 30 days of death, hospital admissions within 30 days of death, time between diagnosis and death, if hospice referral was placed, non-essential medication dispensed, medication de-escalation, and who made the recommendation.
Mengqian Zhu– Resident, Lexington Veterans Affairs Medical Center, Lexington, KY